Correlation Between MediciNova and Revvity
Can any of the company-specific risk be diversified away by investing in both MediciNova and Revvity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Revvity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Revvity, you can compare the effects of market volatilities on MediciNova and Revvity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Revvity. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Revvity.
Diversification Opportunities for MediciNova and Revvity
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between MediciNova and Revvity is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Revvity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revvity and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Revvity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revvity has no effect on the direction of MediciNova i.e., MediciNova and Revvity go up and down completely randomly.
Pair Corralation between MediciNova and Revvity
Given the investment horizon of 90 days MediciNova is expected to generate 2.17 times more return on investment than Revvity. However, MediciNova is 2.17 times more volatile than Revvity. It trades about 0.0 of its potential returns per unit of risk. Revvity is currently generating about 0.0 per unit of risk. If you would invest 210.00 in MediciNova on December 4, 2024 and sell it today you would lose (53.00) from holding MediciNova or give up 25.24% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
MediciNova vs. Revvity
Performance |
Timeline |
MediciNova |
Revvity |
MediciNova and Revvity Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Revvity
The main advantage of trading using opposite MediciNova and Revvity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Revvity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revvity will offset losses from the drop in Revvity's long position.MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Revvity vs. Waters | Revvity vs. IDEXX Laboratories | Revvity vs. IQVIA Holdings | Revvity vs. Charles River Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |